Novan, Inc(NASDAQ:NOVN) 
Novan, Inc., a clinical development-stage biotechnology company, provides nitric oxide-based therapies to treat dermatological and oncovirus-mediated diseases. Its clinical stage dermatology drug candidates include SB204, a topical monotherapy for the treatment of acne vulgaris; SB206, a topical ant...
Website: http://www.novan.com
Founded: 2006
Full Time Employees: 24
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2023-10-27
P
O 0.00
H 0.00
L 0.00
C 0.00
V 0
10EMA
20EMA
60EMA
120EMA
250EMA